Biotage AB (publ)
BITGF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $0 | $1 |
| % Growth | -33.8% | 18.8% | -2.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 62.9% | 61.9% | 61.8% | 64.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | $0 | $0 | -$0 |
| % Margin | -3.1% | 30.1% | 13.3% | -0.8% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | $0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 1% | 27.3% | 9.2% | 9.5% |
| EPS | 0.05 | 1.99 | 0.55 | 0.6 |
| % Growth | -97.5% | 261.8% | -8.3% | – |
| EPS Diluted | 0.05 | 1.98 | 0.56 | 0.6 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 7.3% | 38.1% | 22.7% | 24.4% |